Keeping up with industries and services news from Liechtenstein

Provided by AGP

Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Hilti India Strengthens Academia-Industry Collaboration with Delhi Technology University (DTU) Through Industry-Supported Lab

Hilti India Strengthens Academia-Industry Collaboration with Delhi Technology University (DTU) Through Industry-Supported Lab

Cross-border structuring: what global families need to know about Liechtenstein

Cross-border structuring: what global families need to know about Liechtenstein

More

4BIO Capital strengthens investment leadership with appointment of Therese Liechtenstein as Partner and Tetsu Maruyama as Venture Partner
Mar. 30, 2026

4BIO Capital strengthens investment leadership with appointment of Therese Liechtenstein as Partner and Tetsu Maruyama as Venture Partner

GlobeNewswire, Inc.

The Liechtenstein Enigma: How Lian Original is Disrupting the Global Luxury Monopoly
Jan. 21, 2026

The Liechtenstein Enigma: How Lian Original is Disrupting the Global Luxury Monopoly

EIN Presswire

Ambassador Hana Duke Ibrahimova Joins Youth Power Ventures Senior Leadership
Apr. 24, 2026

Ambassador Hana Duke Ibrahimova Joins Youth Power Ventures Senior Leadership

GlobeNewswire, Inc.

Combi Boiler Market to Reach USD 42.94M by 2032 | Smart & Energy-Efficient Systems Drive Growth
Oct. 9, 2025

Combi Boiler Market to Reach USD 42.94M by 2032 | Smart & Energy-Efficient Systems Drive Growth

EIN Presswire

Diamond Coatings Industry Report: Competitive Landscape and Future Prospects
Sep. 30, 2025

Diamond Coatings Industry Report: Competitive Landscape and Future Prospects

EIN Presswire

Ojemda® approved in the European Union as the first targeted therapy in relapsed or refractory pediatric low-grade glioma regardless of BRAF alteration
Apr. 22, 2026

Ojemda® approved in the European Union as the first targeted therapy in relapsed or refractory pediatric low-grade glioma regardless of BRAF alteration

GlobeNewswire, Inc.

More

Video Stories

YouTube video thumbnail: European Leaders React to U.S. Troop Withdrawal From Germany
Play
European Leaders React to U.S. Troop Withdrawal From Germany
YouTube video thumbnail: How to Spot a Russian Deepfake
Play
How to Spot a Russian Deepfake
YouTube video thumbnail: Russian Strikes Kill 10 as Zelensky Says Ukraine Hits Oil Tankers and Terminal
Play
Russian Strikes Kill 10 as Zelensky Says Ukraine Hits Oil Tankers and Terminal
YouTube video thumbnail: Defence in Focus at European Political Community Summit in Yerevan
Play
Defence in Focus at European Political Community Summit in Yerevan

Video Title

Sign up for Liechtenstein Industry Review.

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Explore More

Share us

on your social networks:

Sign up for Liechtenstein Industry Review.

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.